Stealth BioTherapeutics Corp
c/o Intertrust Corporate Services (Cayman) Limited
190 Elgin Avenue
George Town, Grand Cayman
KY1-9005 Cayman Islands
February 12, 2019
Via EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: | Stealth BioTherapeutics Corp |
Registration Statement on FormF-1 |
File No. 333-229097 |
Request for Acceleration |
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Stealth BioTherapeutics Corp hereby requests acceleration of the effective date of its Registration Statement onForm F-1 (File No. 333-229097), as amended, so that it may become effective at 4:30 p.m. Eastern time on February 14, 2019, or as soon thereafter as practicable.
[The remainder of this page is intentionally left blank.]
Very truly yours,
Stealth BioTherapeutics Corp | ||
By: | /s/ Irene P. McCarthy | |
Name: Title: | Irene P. McCarthy Chief Executive Officer |
[Signature Page to Acceleration Request]